Outlook for the FYE March 2019
JPY 99.5 billion in overall operating income
The year to leap forward; FYE March 2019, the first year of Medium-Term Business Plan Food segment
JPY 90 billion in operating income
• Raise price for some products to offset cost increase in dairy raw materials and logistics
• Expand sales in core and growth domains to drive income Offset the increase in marketing costs with the change in depreciation method (declining-balance method to straight-line method)
Pharmaceutical segment
JPY 10 billion in operating income
• Anticipating income decline in JPY 12.6 billion due to NHI drug price revision Reduce that impact by maintaining price
• Increase sales volumes of brand-name and generic drugs
JPY 99.5 billion in overall operating income
The year to leap forward; FYE March 2019, the first year of Medium-Term Business Plan
Food segment
JPY 90 billion in operating income
• Raise price for some products to offset cost increase in dairy raw materials and logistics
• Expand sales in core and growth domains to drive income
Pharmaceutical segmentOffset the increase in marketing costs with the change in depreciation method (declining-balance method to straight-line method)
JPY 10 billion in operating income
• Anticipating income decline in JPY 12.6 billion due to NHI drug price revision
Reduce that impact by maintaining price
• Increase sales volumes of brand-name and generic drugs
• Lower costs